China Healthwise Holdings (HKSE:00348) Beneish M-Score : -8.36 (As of May. 17, 2024)

View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -8.36 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for China Healthwise Holdings's Beneish M-Score or its related term are showing as below:

HKSE:00348' s Beneish M-Score Range Over the Past 10 Years
Min: -8.36 Med: -2.61 Max: 4.33
Current: -8.36

During the past 13 years, the highest Beneish M-Score of China Healthwise Holdings was 4.33. The lowest was -8.36. And the median was -2.61.

China Healthwise Holdings Beneish M-Score Historical Data

The historical data trend for China Healthwise Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Healthwise Holdings Beneish M-Score Chart

China Healthwise Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

Get a 7-Day Free Trial

-0.69

-2.90

-5.11

-0.48

-8.36

China Healthwise Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beneish M-Score	Get a 7-Day Free Trial															-5.11	-	-0.48	-	-8.36

Competitive Comparison of China Healthwise Holdings's Beneish M-Score

For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Healthwise Holdings's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where China Healthwise Holdings's Beneish M-Score falls into.

China Healthwise Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of China Healthwise Holdings for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 0.176

0.528 * 0.91

0.404 * 0.6629

0.892 * 1.03

0.115 * 0.7957

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.9496

4.679 * -0.995858

0.327 * 1.8762

-8.36

This Year (Dec23) TTM:

Last Year (Dec22) TTM:

Total Receivables was HK$26.0 Mil.
Revenue was HK$146.3 Mil.
Gross Profit was HK$60.3 Mil.
Total Current Assets was HK$139.7 Mil.
Total Assets was HK$149.7 Mil.
Property, Plant and Equipment(Net PPE) was HK$8.0 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$5.6 Mil.
Selling, General, & Admin. Expense(SGA) was HK$65.4 Mil.
Total Current Liabilities was HK$143.0 Mil.
Long-Term Debt & Capital Lease Obligation was HK$2.1 Mil.
Net Income was HK$-134.6 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$14.5 Mil.

Total Receivables was HK$143.5 Mil.
Revenue was HK$142.1 Mil.
Gross Profit was HK$53.3 Mil.
Total Current Assets was HK$275.0 Mil.
Total Assets was HK$287.7 Mil.
Property, Plant and Equipment(Net PPE) was HK$6.8 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$3.3 Mil.
Selling, General, & Admin. Expense(SGA) was HK$66.9 Mil.
Total Current Liabilities was HK$74.8 Mil.
Long-Term Debt & Capital Lease Obligation was HK$73.9 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(26.024 / 146.317)	/	(143.52 / 142.058)
	=	0.17786	/	1.010292
	=	0.176

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(53.27 / 142.058)	/	(60.294 / 146.317)
	=	0.374988	/	0.412078
	=	0.91

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (139.655 + 7.984) / 149.67)	/	(1 - (275.017 + 6.753) / 287.659)
	=	0.01357	/	0.020472
	=	0.6629

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	146.317	/	142.058
	=	1.03

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(3.304 / (3.304 + 6.753))	/	(5.615 / (5.615 + 7.984))
	=	0.328527	/	0.412898
	=	0.7957

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(65.403 / 146.317)	/	(66.872 / 142.058)
	=	0.446995	/	0.470737
	=	0.9496

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((2.149 + 142.953) / 149.67)	/	((73.886 + 74.756) / 287.659)
	=	0.96948	/	0.51673
	=	1.8762

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-134.558 - 0	-	14.492)	/	149.67
	=	-0.995858

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

China Healthwise Holdings has a M-score of -8.36 suggests that the company is unlikely to be a manipulator.

China Healthwise Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

China Healthwise Holdings (HKSE:00348) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG

Website

http://www.healthwisehk.com/en

China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines